Literature DB >> 24692720

Curcumin suppresses vasculogenic mimicry capacity of hepatocellular carcinoma cells through STAT3 and PI3K/AKT inhibition.

Khajeelak Chiablaem1, Kriengsak Lirdprapamongkol, Siriporn Keeratichamroen, Rudee Surarit, Jisnuson Svasti.   

Abstract

BACKGROUND: Vasculogenic mimicry (VM) refers to the process in which highly invasive cancer cells mimic endothelial cells by forming blood channels. In the present study, we investigated the effect of curcumin, a natural product from turmeric, on VM of SK-Hep-1 human hepatocellular carcinoma (HCC) cells.
MATERIALS AND METHODS: In vitro VM, cell migration, and matrix metalloproteinase-9 (MMP9) production of HCC cells were determined by Matrigel tube formation assay, Transwell cell migration assay, and gelatin zymography, respectively. Effects of curcumin on AKT, signal transducer and activator of transcription 3 (STAT3), extracellular signal-regulated kinase (ERK) and nuclear factor-κB (NF-κB) signaling pathways were determined by immunoblot analysis.
RESULTS: At non-cytotoxic concentrations, curcumin inhibited VM, reduced cell migration and MMP9 production of the HCC cells. Further study revealed that the anti-VM effect of curcumin was due to inhibition of AKT and STAT3 phosphorylation, as confirmed by specific inhibitors.
CONCLUSION: Curcumin presents proven potential as an anti-VM agent in HCC cells, through down-regulation of STAT3 and AKT signaling pathways.

Entities:  

Keywords:  Curcumin; antimetastatic; hepatocellular carcinoma; natural products; vasculogenic mimicry

Mesh:

Substances:

Year:  2014        PMID: 24692720

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  27 in total

1.  Curcumin suppresses invasiveness and vasculogenic mimicry of squamous cell carcinoma of the larynx through the inhibition of JAK-2/STAT-3 signaling pathway.

Authors:  An Hu; Jing-Juan Huang; Xiao-Jie Jin; Ji-Ping Li; Yuan-Jia Tang; Xin-Fang Huang; Hui-Juan Cui; Wei-Hua Xu; Guang-Bin Sun
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

2.  Investigation and experimental validation of curcumin-related mechanisms against hepatocellular carcinoma based on network pharmacology.

Authors:  Yang Chen; Qian Li; Sisi Ren; Ting Chen; Bingtao Zhai; Jiangxue Cheng; Xiaoyan Shi; Liang Song; Yu Fan; Dongyan Guo
Journal:  J Zhejiang Univ Sci B       Date:  2022-08-15       Impact factor: 5.552

Review 3.  Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry.

Authors:  Elena Andreucci; Silvia Peppicelli; Jessica Ruzzolini; Francesca Bianchini; Lido Calorini
Journal:  Cancer Metastasis Rev       Date:  2022-10-13       Impact factor: 9.237

4.  Effect of Derris scandens extract on a human hepatocellular carcinoma cell line.

Authors:  Duanghathai Kuljittichanok; Penchatr Diskul-Na-Ayudthaya; Churat Weeraphan; Daranee Chokchaichamnankit; Khajeelak Chiablaem; Kriengsak Lirdprapamongkol; Jisnuson Svasti; Chantragan Srisomsap
Journal:  Oncol Lett       Date:  2018-05-29       Impact factor: 2.967

5.  Curcumin inhibits the growth of liver cancer stem cells through the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway.

Authors:  Ji Wang; Chunying Wang; Gaofeng Bu
Journal:  Exp Ther Med       Date:  2018-01-29       Impact factor: 2.447

6.  Capsaicin suppresses the migration of cholangiocarcinoma cells by down-regulating matrix metalloproteinase-9 expression via the AMPK-NF-κB signaling pathway.

Authors:  Gong-Rak Lee; Soo Hwa Jang; Chang Jae Kim; Ah-Ram Kim; Dong-Joon Yoon; Neung-Hwa Park; In-Seob Han
Journal:  Clin Exp Metastasis       Date:  2014-09-14       Impact factor: 5.150

7.  Curcumin inhibits cell proliferation and promotes apoptosis in human osteoclastoma cell through MMP-9, NF-κB and JNK signaling pathways.

Authors:  Fujiang Cao; Tao Liu; Yunqiang Xu; Dongdong Xu; Shiqing Feng
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

8.  Formulation, Characterization And Evaluation Of Curcumin- Loaded PLGA- TPGS Nanoparticles For Liver Cancer Treatment.

Authors:  Xiao-Ping Chen; Yi Li; Yu Zhang; Gao-Wei Li
Journal:  Drug Des Devel Ther       Date:  2019-10-16       Impact factor: 4.162

Review 9.  Vascular mimicry: changing the therapeutic paradigms in cancer.

Authors:  Nazila Fathi Maroufi; Sina Taefehshokr; Mohammad-Reza Rashidi; Nima Taefehshokr; Mahdieh Khoshakhlagh; Alireza Isazadeh; Narmin Mokarizadeh; Behzad Baradaran; Mohammad Nouri
Journal:  Mol Biol Rep       Date:  2020-05-18       Impact factor: 2.316

10.  Drimane Sesquiterpene-Conjugated Amino Acids from a Marine Isolate of the Fungus Talaromyces minioluteus (Penicillium Minioluteum).

Authors:  Suthatip Ngokpol; Wittaya Suwakulsiri; Sanya Sureram; Kriengsak Lirdprapamongkol; Thammarat Aree; Suthep Wiyakrutta; Chulabhorn Mahidol; Somsak Ruchirawat; Prasat Kittakoop
Journal:  Mar Drugs       Date:  2015-06-05       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.